Patent · US Active

Detection of anti-p53 antibodies

US11971407B2 · kind B2 · utility

1Cited by

8References

18Claims

0Family size

Assignee

Roche Diagnostics Operations, Inc. · US

Inventors

Herbert Andres · Penzberg, DE
Johann Karl · Peißenberg, DE
Ursula Kunert · Munich, DE
David A. Morgenstern · Creve Coeur, US
Nina Meissler · Huglfing, DE
Marion Niessner · Penzberg, DE
Magdalena Swiatek-de Lange · Penzberg, DE

Key dates

Filing date	Apr 27, 2022
Grant date	Apr 30, 2024
Priority date	—
Expiry date	Apr 27, 2042

Classification

Technology area (CPC G)Physics
CPC primaryG01N33/57496
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

An in vitro method is disclosed for detecting an antibody to p53 (anti-p53 antibody) in a sample, the method comprising: incubating a sample to be analyzed with a p53 capture antigen and a p53 detection antigen, whereby a complex comprising the p53 capture antigen, the anti-p53 antibody and the p53 detection antigen is formed, separating the complex formed from unbound detection antigen and measuring the complex obtained via the detection antigen comprised therein, thereby detecting the anti-p53 antibody comprised in the sample.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.